POLYPEPTIDES BINDING TO HUMAN SYNTAXIN 1a

Details for Australian Patent Application No. 2003221433 (hide)

Owner DAIICHI PHARMACEUTICAL CO.,LTD.

Inventors YOKOTA, Hiroshi; SATOH, Kazuki

Pub. Number AU-A-2003221433

PCT Number PCT/JP03/03308

PCT Pub. Number WO2003/078633

Priority 2002-75551 19.03.02 JP

Filing date 19 March 2003

Wipo publication date 29 September 2003

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 035/76 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 038/00 Medicinal preparations containing peptides

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 025/00 Drugs for disorders of the nervous system

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 2002-75551 19.03.02 JP

6 November 2003 Application Open to Public Inspection

  Published as AU-A-2003221433

9 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003221434-AMINOMETHYL-SUBSTITUTED THIAZOLOBENZIMIDAZOLE DERIVATIVE

2003221432-GENE EXAMINATION METHOD FOR JUDGING THE ONSET RISK OF GLAUCOMA